Investor Relations
Sep 14, 2018
OPKO Confirms Resumption of Common Stock Trading on Nasdaq MORE >>
Sep 11, 2018
OPKO Comments on Continued Nasdaq Halt of Trading of Common Stock MORE >>
Sep 07, 2018
OPKO Comments on SEC Complaint MORE >>
Sep 04, 2018
OPKO Initiates RAYALDEE Phase 2 Trial in Dialysis Patients MORE >>

SEC Filing Details

Document Details

Form
Filing Date
May 8, 2018
Document Date
May 8, 2018
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
OPKO Health, Inc.